{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:34:55Z","timestamp":1793885695508,"version":"4.8.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":267,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2026.102501","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:25:46Z","timestamp":1790576746000},"page":"102501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deteriorating fractional exhaled nitric oxide preceding pneumonitis during immune checkpoint inhibitor therapy: a case report"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-6092","authenticated-orcid":false,"given":"M.","family":"H\u00f6gman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2409-1707","authenticated-orcid":false,"given":"J.","family":"Ellingsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3628-4538","authenticated-orcid":false,"given":"Y.","family":"Naeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-5176","authenticated-orcid":false,"given":"A.T.","family":"Dinh-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmcr.2026.102501_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000840","article-title":"Chronic immune checkpoint inhibitor pneumonitis","volume":"8","author":"Naidoo","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.rmcr.2026.102501_bib2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1634\/theoncologist.2018-0352","article-title":"Recurrent pneumonitis in patients with melanoma treated with immune checkpoint inhibitors","volume":"24","author":"Asher","year":"2019","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.rmcr.2026.102501_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.638","article-title":"Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab","volume":"8","author":"Watanabe","year":"2020","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.rmcr.2026.102501_bib4","article-title":"Pembrolizumab-induced asthma exacerbation with hypereosinophilia and elevated interleukin-5 in endometrial cancer: a case report","volume":"49","author":"Harada","year":"2024","journal-title":"Respir Med Case Rep"},{"issue":"10","key":"10.1016\/j.rmcr.2026.102501_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.1222","article-title":"Immune checkpoint inhibitor-induced asthma and chronic obstructive pulmonary disease overlap in patient with adenocarcinoma","volume":"11","author":"Hayakawa","year":"2023","journal-title":"Respirol Case Rep"},{"issue":"4","key":"10.1016\/j.rmcr.2026.102501_bib6","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/adfd04","article-title":"Exhaled nitric oxide stability over two years in relation to COPD outcomes","volume":"19","author":"H\u00f6gman","year":"2025","journal-title":"J. Breath Res."},{"issue":"12","key":"10.1016\/j.rmcr.2026.102501_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/17476348.2024.2433537","article-title":"Measuring exhaled nitric oxide in COPD: from theoretical consideration to practical views","volume":"18","author":"H\u00f6gman","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102501_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12890-024-03180-w","article-title":"The impact of chronic obstructive pulmonary disease on the risk of immune-related pneumonitis in lung cancer patients undergoing immunotherapy: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2024","journal-title":"BMC Pulm. Med."},{"issue":"2","key":"10.1016\/j.rmcr.2026.102501_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000503566","article-title":"Landscape of immune-related pneumonitis in cancer patients with asthma being treated with immune checkpoint blockade","volume":"98","author":"Galant-Swafford","year":"2020","journal-title":"Oncology"},{"key":"10.1016\/j.rmcr.2026.102501_bib10","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2147\/COPD.S490252","article-title":"COPD and immune checkpoint inhibitors for cancer: a literature review","volume":"19","author":"Lycan","year":"2024","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmcr.2026.102501_bib11","first-page":"1","article-title":"Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study","volume":"0","author":"Karayama","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.rmcr.2026.102501_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/COPD.S214610","article-title":"Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD","volume":"14","author":"Suzuki","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"6","key":"10.1016\/j.rmcr.2026.102501_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153289","article-title":"Investigating the role of TNF-alpha and IFN-gamma activation on the dynamics of iNOS gene expression in LPS stimulated macrophages","volume":"11","author":"Salim","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.rmcr.2026.102501_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/cdd.2014.85","article-title":"Interleukin-17 enhances immunosuppression by mesenchymal stem cells","volume":"21","author":"Han","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.rmcr.2026.102501_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13578-020-00431-1","article-title":"Interleukin-17 promotes nitric oxide-dependent expression of PD-L1 in mesenchymal stem cells","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci."},{"issue":"17","key":"10.1016\/j.rmcr.2026.102501_bib16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2217\/imt-2022-0094","article-title":"Fractional exhaled nitric oxide in checkpoint inhibitor pneumonitis: a case report and literature review","volume":"14","author":"Wu","year":"2022","journal-title":"Immunotherapy"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:14:18Z","timestamp":1793884458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007126001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"alternative-id":["S2213007126001383"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102501","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deteriorating fractional exhaled nitric oxide preceding pneumonitis during immune checkpoint inhibitor therapy: a case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102501"}}